CAR and PXR: The xenobiotic-sensing receptors

Steroids

Volumn 72, Issue 3, 2007, Pages 231-246

  Timsit, Yoav E ^a   Negishi, Masahiko ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Constitutive androstane receptor; Estrogen receptor; Glucocorticoid receptor; Physiology; Pregnane X receptor; Structure function relationship

Indexed keywords

CELL NUCLEUS RECEPTOR; CHEMICAL AGENT; CONSTITUTIVE ANDROSTANE RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; PREGNANE X RECEPTOR; STEROID HORMONE; STEROID RECEPTOR; XENOBIOTIC AGENT;

CRYSTAL STRUCTURE; GLUCONEOGENESIS; HOMEOSTASIS; HORMONAL REGULATION; INTRACELLULAR TRANSPORT; MULTIGENE FAMILY; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; REVIEW; SENSOR; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 CYP3A; HUMANS; LIGANDS; METABOLIC DETOXICATION, DRUG; MICE; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RATS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; XENOBIOTICS;

EID: 33847024555     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.steroids.2006.12.006     Document Type: Review

References (121)

1. Kodama S., and Negishi M. Phenobarbital confers its diverse effects by activating the orphan nuclear receptor CAR. Drug Metab Rev 38 (2006) 75-87
2. Sueyoshi T., and Negishi M. Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41 (2001) 123-143
3. Swales K., Kakizaki S., Yamamoto Y., Inoue K., Kobayashi K., and Negishi M. Novel CAR-mediated mechanism for synergistic activation of two distinct elements within the human cytochrome P450 2B6 gene in HepG2 cells. J Biol Chem 280 (2005) 3458-3466
4. Qatanani M., Zhang J., and Moore D.D. Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism. Endocrinology 146 (2005) 995-1002
5. Maglich J.M., Watson J., McMillen P.J., Goodwin B., Willson T.M., and Moore J.T. The nuclear receptor CAR is a regulator of thyroid hormone metabolism during caloric restriction. J Biol Chem 279 (2004) 19832-19838
6. Quattrochi L.C., and Guzelian P.S. CYP3A regulation: from pharmacology to nuclear receptors. Drug Metab Dispos 29 (2001) 615-622
7. Miao J., Fang S., Bae Y., and Kemper J.K. Functional inhibitory cross-talk between constitutive androstane receptor and hepatic nuclear factor-4 in hepatic lipid/glucose metabolism is mediated by competition for binding to the DR1 motif and to the common coactivators, GRIP-1 and PGC-1α. J Biol Chem 281 (2006) 14537-14546
8. Kodama S., Koike C., Negishi M., and Yamamoto Y. Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol 24 (2004) 7931-7940
9. Lahtela J.T., Arranto A.J., and Sotaniemi E.A. Enzyme inducers improve insulin sensitivity in non-insulin-dependent diabetic subjects. Diabetes 34 (1985) 911-916
10. Staudinger J.L., Goodwin B., Jones S.A., Hawkins-Brown D., MacKenzie K.I., LaTour A., et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 98 (2001) 3369-3374
11. Xie W., Radominska-Pandya A., Shi Y., Simon C.M., Nelson M.C., Ong E.S., et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 98 (2001) 3375-3380
12. Goodwin B., Gauthier K.C., Umetani M., Watson M.A., Lochansky M.I., Collins J.L., et al. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA 100 (2003) 223-228
13. Sonoda J., Chong L.W., Downes M., Barish G.D., Coulter S., Liddle C., et al. Pregnane X receptor prevents hepatorenal toxicity from cholesterol metabolites. Proc Natl Acad Sci USA 102 (2005) 2198-2203
14. Goodwin B., and Kliewer S.A. Nuclear receptors. I. Nuclear receptors and bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol 282 (2002) G926-G931
15. Zhang J., Huang W., Qatanani M., Evans R.M., and Moore D.D. The constitutive androstane receptor and pregnane X receptor function coordinately to prevent bile acid-induced hepatotoxicity. J Biol Chem 279 (2004) 49517-49522
16. Maglich J.M., Parks D.J., Moore L.B., Collins J.L., Goodwin B., Billin A.N., et al. Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278 (2003) 17277-17283
17. Tzameli I., Pissios P., Schuetz E.G., and Moore D.D. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol 20 (2000) 2951-2958
18. Willson T.M., and Kliewer S.A. PXR, CAR and drug metabolism. Nat Rev Drug Discov 1 (2002) 259-266
19. Goodwin B., Redinbo M.R., and Kliewer S.A. Regulation of CYP3A gene transcription by the pregnane X receptor. Annu Rev Pharmacol Toxicol 42 (2002) 1-23
20. Kliewer S.A., Goodwin B., and Willson T.M. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 23 (2002) 687-702
21. Koike C., Moore R., and Negishi M. Localization of the nuclear receptor CAR at the cell membrane of mouse liver. FEBS Lett 579 (2005) 6733-6736
22. Choi E., Lee S., Yeom S.Y., Kim G.H., Lee J.W., and Kim S.W. Characterization of activating signal cointegrator-2 as a novel transcriptional coactivator of the xenobiotic nuclear receptor constitutive androstane receptor. Mol Endocrinol 19 (2005) 1711-1719
23. Kim H.J., Lee S.K., Na S.Y., Choi H.S., and Lee J.W. Molecular cloning of xSRC-3, a novel transcription coactivator from Xenopus, that is related to AIB1, p/CIP, and TIF2. Mol Endocrinol 12 (1998) 1038-1047
24. Min G., Kemper J.K., and Kemper B. Glucocorticoid receptor-interacting protein 1 mediates ligand-independent nuclear translocation and activation of constitutive androstane receptor in vivo. J Biol Chem 277 (2002) 26356-26363
25. Muangmoonchai R., Smirlis D., Wong S.C., Edwards M., Phillips I.R., and Shephard E.A. Xenobiotic induction of cytochrome P450 2B1 (CYP2B1) is mediated by the orphan nuclear receptor constitutive androstane receptor (CAR) and requires steroid co-activator 1 (SRC-1) and the transcription factor Sp1. Biochem J 355 (2001) 71-78
26. Shiraki T., Sakai N., Kanaya E., and Jingami H. Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor γ coactivator-1αṡ A possible link between xenobiotic response and nutritional state. J Biol Chem 278 (2003) 11344-11350
27. Inoue K., Borchers C.H., and Negishi M. Cohesin protein SMC1 represses the nuclear receptor CAR-mediated synergistic activation of a human P450 gene by xenobiotics. Biochem J 398 (2006) 125-133
28. Kawamoto T., Sueyoshi T., Zelko I., Moore R., Washburn K., and Negishi M. Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19 (1999) 6318-6322
29. Sidhu J.S., and Omiecinski C.J. An okadaic acid-sensitive pathway involved in the phenobarbital-mediated induction of CYP2B gene expression in primary rat hepatocyte cultures. J Pharmacol Exp Ther 282 (1997) 1122-1129
30. Honkakoski P., and Negishi M. Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem J 330 (1998) 889-895
31. Zelko I., Sueyoshi T., Kawamoto T., Moore R., and Negishi M. The peptide near the C terminus regulates receptor CAR nuclear translocation induced by xenochemicals in mouse liver. Mol Cell Biol 21 (2001) 2838-2846
32. Kobayashi K., Sueyoshi T., Inoue K., Moore R., and Negishi M. Cytoplasmic accumulation of the nuclear receptor CAR by a tetratricopeptide repeat protein in HepG2 cells. Mol Pharmacol 64 (2003) 1069-1075
33. Yoshinari K., Kobayashi K., Moore R., Kawamoto T., and Negishi M. Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital. FEBS Lett 548 (2003) 17-20
34. Hosseinpour F., Moore R., Negishi M., and Sueyoshi T. Serine 202 regulates the nuclear translocation of constitutive active/androstane receptor. Mol Pharmacol 69 (2006) 1095-1102
35. Xia J., and Kemper B. Structural determinants of constitutive androstane receptor required for its glucocorticoid receptor interacting protein-1-mediated nuclear accumulation. J Biol Chem 280 (2005) 7285-7293
36. Jia Y., Guo G.L., Surapureddi S., Sarkar J., Qi C., Guo D., et al. Transcription coactivator peroxisome proliferator-activated receptor-binding protein/mediator 1 deficiency abrogates acetaminophen hepatotoxicity. Proc Natl Acad Sci USA 102 (2005) 12531-12536
37. Squires E.J., Sueyoshi T., and Negishi M. Cytoplasmic localization of pregnane X receptor and ligand-dependent nuclear translocation in mouse liver. J Biol Chem 279 (2004) 49307-49314
38. Orans J., Teotico D.G., and Redinbo M.R. The nuclear xenobiotic receptor pregnane X receptor: recent insights and new challenges. Mol Endocrinol 19 (2005) 2891-2900
39. Ding X., and Staudinger J.L. Induction of drug metabolism by forskolin: the role of the pregnane X receptor and the protein kinase A signal transduction pathway. J Pharmacol Exp Ther 312 (2005) 849-856
40. Ding X., and Staudinger J.L. Repression of PXR-mediated induction of hepatic CYP3A gene expression by protein kinase C. Biochem Pharmacol 69 (2005) 867-873
41. Kawamoto T., Kakizaki S., Yoshinari K., and Negishi M. Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Mol Endocrinol 14 (2000) 1897-1905
42. Ueda A., Kakizaki S., Negishi M., and Sueyoshi T. Residue threonine 350 confers steroid hormone responsiveness to the mouse nuclear orphan receptor CAR. Mol Pharmacol 61 (2002) 1284-1288
43. Ueda A., Matsui K., Yamamoto Y., Pedersen L.C., Sueyoshi T., and Negishi M. Thr176 regulates the activity of the mouse nuclear receptor CAR and is conserved in the NR1I subfamily members PXR and VDR. Biochem J 388 (2005) 623-630
44. Dussault I., Lin M., Hollister K., Fan M., Termini J., Sherman M.A., et al. A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol Cell Biol 22 (2002) 5270-5280
45. Frank C., Molnar F., Matilainen M., Lempiainen H., and Carlberg C. Agonist-dependent and agonist-independent transactivations of the human constitutive androstane receptor are modulated by specific amino acid pairs. J Biol Chem 279 (2004) 33558-33566
46. Jyrkkarinne J., Windshugel B., Makinen J., Ylisirnio M., Perakyla M., Poso A., et al. Amino acids important for ligand specificity of the human constitutive androstane receptor. J Biol Chem 280 (2005) 5960-5971
47. Xu R.X., Lambert M.H., Wisely B.B., Warren E.N., Weinert E.E., Waitt G.M., et al. A structural basis for constitutive activity in the human CAR/RXRalpha heterodimer. Mol Cell 16 (2004) 919-928
48. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389 (1997) 753-758
49. Tanenbaum D.M., Wang Y., Williams S.P., and Sigler P.B. Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. Proc Natl Acad Sci USA 95 (1998) 5998-6003
50. Suino K., Peng L., Reynolds R., Li Y., Cha J.Y., Repa J.J., et al. The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization. Mol Cell 16 (2004) 893-905
51. Shan L., Vincent J., Brunzelle J.S., Dussault I., Lin M., Ianculescu I., et al. Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism. Mol Cell 16 (2004) 907-917
52. Xiao L., Cui X., Madison V., White R.E., and Cheng K.C. Insights from a three-dimensional model into ligand binding to constitutive active receptor. Drug Metab Dispos 30 (2002) 951-956
53. Poso A., and Honkakoski P. Ligand recognition by drug-activated nuclear receptors PXR and CAR: structural, site-directed mutagenesis and molecular modeling studies. Mini Rev Med Chem 6 (2006) 937-947
54. Windshugel B., Jyrkkarinne J., Vanamo J., Poso A., Honkakoski P., and Sippl W. Comparison of homology models and X-ray structures of the nuclear receptor CAR: assessing the structural basis of constitutive activity. J Mol Graph Model (2006)
55. Watkins R.E., Noble S.M., and Redinbo M.R. Structural insights into the promiscuity and function of the human pregnane X receptor. Curr Opin Drug Discov Dev 5 (2002) 150-158
56. Watkins R.E., Wisely G.B., Moore L.B., Collins J.L., Lambert M.H., Williams S.P., et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 292 (2001) 2329-2333
57. Chrencik J.E., Orans J., Moore L.B., Xue Y., Peng L., Collins J.L., et al. Structural disorder in the complex of human pregnane X receptor and the macrolide antibiotic rifampicin. Mol Endocrinol 19 (2005) 1125-1134
58. Watkins R.E., Maglich J.M., Moore L.B., Wisely G.B., Noble S.M., Davis-Searles P.R., et al. 2.1 Å crystal structure of human PXR in complex with the St. John's Wort compound hyperforin. Biochemistry 42 (2003) 1430-1438
59. Watkins R.E., Davis-Searles P.R., Lambert M.H., and Redinbo M.R. Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol 331 (2003) 815-828
60. Masuyama H., Suwaki N., Tateishi Y., Nakatsukasa H., Segawa T., and Hiramatsu Y. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol Endocrinol 19 (2005) 1170-1180
61. Zhou J., and Cidlowski J.A. The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70 (2005) 407-417
62. Kato S., Endoh H., Masuhiro Y., Kitamoto T., Uchiyama S., Sasaki H., et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 (1995) 1491-1494
63. Kumar V., Green S., Stack G., Berry M., Jin J.R., and Chambon P. Functional domains of the human estrogen receptor. Cell 51 (1987) 941-951
64. Kumar R., and Thompson E.B. Gene regulation by the glucocorticoid receptor: structure:function relationship. J Steroid Biochem Mol Biol 94 (2005) 383-394
65. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., et al. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 (1998) 927-937
66. Shiau A.K., Barstad D., Radek J.T., Meyers M.J., Nettles K.W., Katzenellenbogen B.S., et al. Structural characterization of a subtype-selective ligand reveals a novel mode of estrogen receptor antagonism. Nat Struct Biol 9 (2002) 359-364
67. Bledsoe R.K., Stewart E.L., and Pearce K.H. Structure and function of the glucocorticoid receptor ligand binding domain. Vitamin Horm 68 (2004) 49-91
68. Noble S.M., Carnahan V.E., Moore L.B., Luntz T., Wang H., Ittoop O.R., et al. Human PXR forms a tryptophan zipper-mediated homodimer. Biochemistry 45 (2006) 8579-8589
69. Oxelmark E., Roth J.M., Brooks P.C., Braunstein S.E., Schneider R.J., and Garabedian M.J. The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion. Mol Cell Biol 26 (2006) 5205-5213
70. Ogawa S., Oishi H., Mezaki Y., Kouzu-Fujita M., Matsuyama R., Nakagomi M., et al. Repressive domain of unliganded human estrogen receptor α associates with Hsc70. Genes Cells 10 (2005) 1095-1102
71. Oxelmark E., Knoblauch R., Arnal S., Su L.F., Schapira M., and Garabedian M.J. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling. J Biol Chem 278 (2003) 36547-36555
72. Schlegel A., Wang C., Katzenellenbogen B.S., Pestell R.G., and Lisanti M.P. Caveolin-1 potentiates estrogen receptor α (ERα) signaling. Caveolin-1 drives ligand-independent nuclear translocation and activation of ERα. J Biol Chem 274 (1999) 33551-33556
73. Knoblauch R., and Garabedian M.J. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction. Mol Cell Biol 19 (1999) 3748-3759
74. Devin-Leclerc J., Meng X., Delahaye F., Leclerc P., Baulieu E.E., and Catelli M.G. Interaction and dissociation by ligands of estrogen receptor and Hsp90: the antiestrogen RU 58668 induces a protein synthesis-dependent clustering of the receptor in the cytoplasm. Mol Endocrinol 12 (1998) 842-854
75. Inano K., Curtis S.W., Korach K.S., Omata S., and Horigome T. Heat shock protein 90 strongly stimulates the binding of purified estrogen receptor to its responsive element. J Biochem (Tokyo) 116 (1994) 759-766
76. Schaaf M.J., and Cidlowski J.A. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 83 (2002) 37-48
77. Evinger III A.J., and Levin E.R. Requirements for estrogen receptor alpha membrane localization and function. Steroids 70 (2005) 361-363
78. Thomas P., Pang Y., Filardo E.J., and Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146 (2005) 624-632
79. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., and Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307 (2005) 1625-1630
80. Pedram A., Razandi M., and Levin E.R. Nature of functional estrogen receptors at the plasma membrane. Mol Endocrinol 20 (2006) 1996-2009
81. Brychzy A., Rein T., Winklhofer K.F., Hartl F.U., Young J.C., and Obermann W.M. Cofactor Tpr2 combines two TPR domains and a J domain to regulate the Hsp70/Hsp90 chaperone system. EMBO J 22 (2003) 3613-3623
82. Likhite V.S., Stossi F., Kim K., Katzenellenbogen B.S., and Katzenellenbogen J.A. Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, DNA, and coregulators associated with alterations in estrogen and tamoxifen activity. Mol Endocrinol (2006)
83. Lipfert L., Fisher J.E., Wei N., Scafonas A., Su Q., Yudkovitz J., et al. Antagonist-induced, activation function-2-independent estrogen receptor α phosphorylation. Mol Endocrinol 20 (2006) 516-533
84. Lee H., and Bai W. Regulation of estrogen receptor nuclear export by ligand-induced and p38-mediated receptor phosphorylation. Mol Cell Biol 22 (2002) 5835-5845
85. Bodwell J.E., Orti E., Coull J.M., Pappin D.J., Smith L.I., and Swift F. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J Biol Chem 266 (1991) 7549-7555
86. Almlof T., Wright A.P., and Gustafsson J.A. Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J Biol Chem 270 (1995) 17535-17540
87. Galigniana M.D., Housley P.R., DeFranco D.B., and Pratt W.B. Inhibition of glucocorticoid receptor nucleocytoplasmic shuttling by okadaic acid requires intact cytoskeleton. J Biol Chem 274 (1999) 16222-16227
88. Pascussi J.M., Gerbal-Chaloin S., Drocourt L., Maurel P., and Vilarem M.J. The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors. Biochim Biophys Acta 1619 (2003) 243-253
89. Pascussi J.M., Drocourt L., Gerbal-Chaloin S., Fabre J.M., Maurel P., and Vilarem M.J. Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. Sequential role of glucocorticoid receptor and pregnane X receptor. Eur J Biochem 268 (2001) 6346-6358
90. Agrawal A.K., and Shapiro B.H. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose. Mol Pharmacol 49 (1996) 523-531
91. Chang T.K.H., Anderson M.D., Bandiera S.M., and Bellward G.D. Effect of ovariectomy and androgen on phenobarbital induction of hepatic CYP2B1 and CYP2B2 in Sprague-Dawley rats. Drug Metab Dispos 25 (1997) 994-1000
92. Yoshinari K., Sueyoshi T., Moore R., and Negishi M. Nuclear receptor CAR as a regulatory factor for the sexually dimorphic induction of CYB2B1 gene by phenobarbital in rat livers. Mol Pharmacol 59 (2001) 278-284
93. Min G., Kim H., Bae Y., Petz L., and Kemper J.K. Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators. J Biol Chem 277 (2002) 34626-34633
94. Ganem L.G., Trottier E., Anderson A., and Jefcoate C.R. Phenobarbital induction of CYP2B1/2 in primary hepatocytes: endocrine regulation and evidence for a single pathway for multiple inducers. Toxicol Appl Pharmacol 155 (1999) 32-42
95. Kietzmann T., Hirsch-Ernst K.I., Kahl G.F., and Jungermann K. Mimicry in primary rat hepatocyte cultures of the in vivo perivenous induction by phenobarbital of cytochrome P-450 2B1 mRNA: role of epidermal growth factor and perivenous oxygen tension. Mol Pharmacol 56 (1999) 46-53
96. Bauer D., Wolfram N., Kahl G.F., and Hirsch-Ernst K.I. Transcriptional regulation of CYP2B1 induction in primary rat hepatocyte cultures: repression by epidermal growth factor is mediated via a distal enhancer region. Mol Pharmacol 65 (2004) 172-180
97. Assenat E., Gerbal-Chaloin S., Larrey D., Saric J., Fabre J.M., Maurel P., et al. Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology 40 (2004) 951-960
98. Thasler W.E., Dayoub R., Muhlbauer M., Hellerbrand C., Singer T., Grabe A., et al. Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor, augmenter of liver regeneration. J Pharmacol Exp Ther 316 (2006) 822-829
99. Pascussi J.M., Gerbal-Chaloin S., Pichard-Garcia L., Daujat M., Fabre J.M., Maurel P., et al. Interleukin-6 negatively regulates the expression of pregnane X receptor and constitutively activated receptor in primary human hepatocytes. Biochem Biophys Res Commun 274 (2000) 707-713
100. Columbano A., Ledda-Columbano G.M., Pibiri M., Cossu C., Menegazzi M., Moore D.D., et al. Gadd45β is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. Hepatology 42 (2005) 1118-1126
101. Masuyama H., Inoshita H., Hiramatsu Y., and Kudo T. Ligands have various potential effects on the degradation of pregnane X receptor by proteasome. Endocrinology 143 (2002) 55-61
102. Chen D., Riedl T., Washbrook E., Pace P.E., Coombes R.C., Egly J.M., et al. Activation of estrogen receptor α by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell 6 (2000) 127-137
103. Lu Q., Ebling H., Mittler J., Baur W.E., and Karas R.H. MAP kinase mediates growth factor-induced nuclear translocation of estrogen receptor α. FEBS Lett 516 (2002) 1-8
104. Itoh M., Adachi M., Yasui H., Takekawa M., Tanaka H., and Imai K. Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. Mol Endocrinol 16 (2002) 2382-2392
105. DeFranco D.B., Qi M., Borror K.C., Garabedian M.J., and Brautigan D.L. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticoid receptors. Mol Endocrinol 5 (1991) 1215-1228
106. Fan M., Park A., and Nephew K.P. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha. Mol Endocrinol 19 (2005) 2901-2914
107. Reid G., Hubner M.R., Metivier R., Brand H., Denger S., Manu D., et al. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11 (2003) 695-707
108. Tateishi Y., Kawabe Y., Chiba T., Murata S., Ichikawa K., Murayama A., et al. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor. EMBO J 23 (2004) 4813-4823
109. Tateishi Y., Sonoo R., Sekiya Y.I., Sunahara N., Kawano M., Wayama M., et al. Turning off estrogen receptor β-mediated transcription requires estrogen-dependent receptor proteolysis. Mol Cell Biol (2006)
110. Connell P., Ballinger C.A., Jiang J., Wu Y., Thompson L.J., Hohfeld J., et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat Cell Biol 3 (2001) 93-96
111. Wallace A.D., and Cidlowski J.A. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem 276 (2001) 42714-42721
112. Binart N., Lombes M., and Baulieu E.E. Distinct functions of the 90 kDa heat-shock protein (hsp90) in oestrogen and mineralocorticosteroid receptor activity: effects of hsp90 deletion mutants. Biochem J 311 (1995) 797-804
113. Pratt W.B., Galigniana M.D., Harrell J.M., and DeFranco D.B. Role of hsp90 and the hsp90-binding immunophilins in signalling protein movement. Cell Signal 16 (2004) 857-872
114. Davies T.H., Ning Y.M., and Sanchez E.R. A new first step in activation of steroid receptors: hormone-induced switching of FKBP51 and FKBP52 immunophilins. J Biol Chem 277 (2002) 4597-4600
115. Kino T., Tiulpakov A., Ichijo T., Chheng L., Kozasa T., and Chrousos G.P. G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol 169 (2005) 885-896
116. Freedman N.D., and Yamamoto K.R. Importin 7 and importin α/importin β are nuclear import receptors for the glucocorticoid receptor. Mol Biol Cell 15 (2004) 2276-2286
117. Holaska J.M., Black B.E., Love D.C., Hanover J.A., Leszyk J., and Paschal B.M. Calreticulin is a receptor for nuclear export. J Cell Biol 152 (2001) 127-140
118. Walther R.F., Lamprecht C., Ridsdale A., Groulx I., Lee S., Lefebvre Y.A., et al. Nuclear export of the glucocorticoid receptor is accelerated by cell fusion-dependent release of calreticulin. J Biol Chem 278 (2003) 37858-37864
119. Kino T., Souvatzoglou E., De Martino M.U., Tsopanomihalu M., Wan Y., and Chrousos G.P. Protein 14-3-3σ interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J Biol Chem 278 (2003) 25651-25656
120. Eickelberg O., Roth M., Lorx R., Bruce V., Rudiger J., Johnson M., et al. Ligand-independent activation of the glucocorticoid receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. J Biol Chem 274 (1999) 1005-1010
121. Carey K.L., Richards S.A., Lounsbury K.M., and Macara I.G. Evidence using a green fluorescent protein-glucocorticoid receptor chimera that the Ran/TC4 GTPase mediates an essential function independent of nuclear protein import. J Cell Biol 133 (1996) 985-996